BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 8219201)

  • 1. Trisomy 21 in childhood acute lymphoblastic leukemia: a Pediatric Oncology Group study (8602).
    Watson MS; Carroll AJ; Shuster JJ; Steuber CP; Borowitz MJ; Behm FG; Pullen DJ; Land VJ
    Blood; 1993 Nov; 82(10):3098-102. PubMed ID: 8219201
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Presenting characteristics of trisomy 8 as the primary cytogenetic abnormality associated with childhood acute lymphoblastic leukemia. A Pediatric Oncology Group (POG) Study (8600/8493).
    Pettenati MJ; Rao N; Wofford M; Shuster JJ; Pullen DJ; Ling MP; Steuber CP; Carroll AJ
    Cancer Genet Cytogenet; 1994 Jul; 75(1):6-10. PubMed ID: 8039165
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Down syndrome childhood acute lymphoblastic leukemia has a unique spectrum of sentinel cytogenetic lesions that influences treatment outcome: a report from the Children's Oncology Group.
    Maloney KW; Carroll WL; Carroll AJ; Devidas M; Borowitz MJ; Martin PL; Pullen J; Whitlock JA; Willman CL; Winick NJ; Camitta BM; Hunger SP
    Blood; 2010 Aug; 116(7):1045-50. PubMed ID: 20442364
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trisomy 21 as the sole acquired chromosomal abnormality in children with acute lymphoblastic leukemia.
    Raimondi SC; Pui CH; Head D; Behm F; Privitera E; Roberson PK; Rivera GK; Williams DL
    Leukemia; 1992 Mar; 6(3):171-5. PubMed ID: 1533007
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison of acute lymphoblastic leukemia in Down syndrome and non-Down syndrome children: the role of trisomy 21.
    Tigay JH
    J Pediatr Oncol Nurs; 2009; 26(6):362-8. PubMed ID: 20032297
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trisomy 5 as a sole cytogenetic abnormality in pediatric acute lymphoblastic leukemia.
    Sandoval C; Mayer SP; Ozkaynak MF; Tugal O; Jayabose S
    Cancer Genet Cytogenet; 2000 Apr; 118(1):69-71. PubMed ID: 10731595
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lymphoblast biology and outcome among children with Down syndrome and ALL treated on CCG-1952.
    Bassal M; La MK; Whitlock JA; Sather HN; Heerema NA; Gaynon PS; Stork LC
    Pediatr Blood Cancer; 2005 Jan; 44(1):21-8. PubMed ID: 15368546
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A case of Down syndrome with acute lymphoblastic leukemia and isochromosome Xp.
    Baker JM; Coppes MJ; Roland B
    Cancer Genet Cytogenet; 2003 Nov; 147(1):75-7. PubMed ID: 14580775
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical and genetic features of pediatric acute lymphoblastic leukemia in Down syndrome in the Nordic countries.
    Lundin C; Forestier E; Klarskov Andersen M; Autio K; Barbany G; Cavelier L; Golovleva I; Heim S; Heinonen K; Hovland R; Johannsson JH; Kjeldsen E; Nordgren A; Palmqvist L; Johansson B; ; ;
    J Hematol Oncol; 2014 Apr; 7():32. PubMed ID: 24726034
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is trisomy 5 a distinct cytogenetic subgroup in acute lymphoblastic leukemia?
    Harris RL; Harrison CJ; Martineau M; Taylor KE; Moorman AV
    Cancer Genet Cytogenet; 2004 Jan; 148(2):159-62. PubMed ID: 14734231
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic significance of cytogenetic abnormalities of chromosome arm 12p in childhood acute lymphoblastic leukemia: a report from the Children's Cancer Group.
    Heerema NA; Sather HN; Sensel MG; Lee MK; Hutchinson R; Nachman JB; Lange BJ; Steinherz PG; Bostrom B; Gaynon PS; Uckun FM
    Cancer; 2000 Apr; 88(8):1945-54. PubMed ID: 10760773
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytogenetic features of acute lymphoblastic and myeloid leukemias in pediatric patients with Down syndrome: an iBFM-SG study.
    Forestier E; Izraeli S; Beverloo B; Haas O; Pession A; Michalová K; Stark B; Harrison CJ; Teigler-Schlegel A; Johansson B
    Blood; 2008 Feb; 111(3):1575-83. PubMed ID: 17971484
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Down's syndrome in childhood acute lymphoblastic leukemia: clinical characteristics and treatment outcome in four consecutive BFM trials. Berlin-Frankfurt-Münster Group.
    Dördelmann M; Schrappe M; Reiter A; Zimmermann M; Graf N; Schott G; Lampert F; Harbott J; Niemeyer C; Ritter J; Dörffel W; Nessler G; Kühl J; Riehm H
    Leukemia; 1998 May; 12(5):645-51. PubMed ID: 9593260
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical and cytogenetic features of hematologic malignancies associated with acquired trisomy 21].
    Wang H; Ni W; Chen Z; Lou J; Xu H; Yu Y; Qian W; Jin J
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2008 Oct; 25(5):576-8. PubMed ID: 18841576
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oligo-based aCGH analysis reveals cryptic unbalanced der(6)t(X;6) in pediatric t(12;21)-positive acute lymphoblastic leukemia.
    Kjeldsen E
    Exp Mol Pathol; 2016 Aug; 101(1):38-43. PubMed ID: 27215399
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute lymphoblastic leukemia and Down syndrome: presenting features and treatment outcome in the experience of the Italian Association of Pediatric Hematology and Oncology (AIEOP).
    Arico M; Ziino O; Valsecchi MG; Cazzaniga G; Baronci C; Messina C; Pession A; Santoro N; Basso G; Conter V;
    Cancer; 2008 Aug; 113(3):515-21. PubMed ID: 18521927
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk- and response-based classification of childhood B-precursor acute lymphoblastic leukemia: a combined analysis of prognostic markers from the Pediatric Oncology Group (POG) and Children's Cancer Group (CCG).
    Schultz KR; Pullen DJ; Sather HN; Shuster JJ; Devidas M; Borowitz MJ; Carroll AJ; Heerema NA; Rubnitz JE; Loh ML; Raetz EA; Winick NJ; Hunger SP; Carroll WL; Gaynon PS; Camitta BM
    Blood; 2007 Feb; 109(3):926-35. PubMed ID: 17003380
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High modal number and triple trisomies are highly correlated favorable factors in childhood B-cell precursor high hyperdiploid acute lymphoblastic leukemia treated according to the NOPHO ALL 1992/2000 protocols.
    Paulsson K; Forestier E; Andersen MK; Autio K; Barbany G; Borgström G; Cavelier L; Golovleva I; Heim S; Heinonen K; Hovland R; Johannsson JH; Kjeldsen E; Nordgren A; Palmqvist L; Johansson B; ; ;
    Haematologica; 2013 Sep; 98(9):1424-32. PubMed ID: 23645689
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical significance of cytogenetic findings at diagnosis and in remission in childhood and adult acute lymphoblastic leukemia: experience from India.
    Amare P; Gladstone B; Varghese C; Pai S; Advani S
    Cancer Genet Cytogenet; 1999 Apr; 110(1):44-53. PubMed ID: 10198622
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Array comparative genome hybridization analysis of acute lymphoblastic leukaemia and acute megakaryoblastic leukaemia in patients with Down syndrome.
    Lo KC; Chalker J; Strehl S; Neat M; Smith O; Dastugue N; Kearney L; Izraeli S; Kempski H; Cowell JK
    Br J Haematol; 2008 Sep; 142(6):934-45. PubMed ID: 18557744
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.